Paving the critical path of drug development: the CDER perspective

First Page		Document Content
Date: 2014-10-31 02:12:55 Health Pharmaceutical industry Drug discovery Food and Drug Administration Clinical research Drug development Center for Drug Evaluation and Research Regulatory science DDT Pharmaceutical sciences Pharmacology Research		Paving the critical path of drug development: the CDER perspective Add to Reading List Source URL: www.nature.com Download Document from Source Website File Size: 584,15 KB Share Document on Facebook

	PDF Document DocID: 1xvUb - View Document
	PDF Document DocID: 1xc8R - View Document
	Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME DocID: 1vqsj - View Document
	Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia DocID: 1vlJU - View Document
	Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology DocID: 1vk1K - View Document